← Browse by Condition
Medical Condition

hr low positive her2 negative breast neoplasms

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06966700 Phase 3
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Enrollment
2,400 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
View Trial →